In Brief Fred Hutch receives $13M SPORE for immunotherapy, lung cancer research December 20, 2019Vol.46 No.01
In Brief Mt. Sinai receives $10M in NIH funding for brain tumor research December 20, 2019Vol.46 No.01
In Brief Ten oncology practices in underserved communities receive ASCO funding to participate in quality improvement programs December 20, 2019Vol.46 No.01
In Brief PharmaMar and Jazz Pharmaceuticals sign license agreement for lurbinectedin in U.S. December 20, 2019Vol.46 No.01
Fox Chase acquired by Jefferson in definitive agreement with Temple December 20, 2019Vol.46 No.01By Matthew Bin Han Ong
Trump approves $212.5M increase to improve NCI success rates; FY20 spending bills provide new funding for childhood cancer, raise tobacco-purchase age to 21 December 20, 2019Vol.46 No.01By Alexandria Carolan and Matthew Bin Han Ong
Moffitt CEO Alan List, director Thomas Sellers resign over conflicts of interests involving China December 20, 2019Vol.46 No.01By Matthew Bin Han Ong
Pazdur on the challenge of approving drugs for small indicationsODAC recommends approval for tazemetostat in rare sarcoma, sNDAs for Lynparza, Keytruda December 20, 2019Vol.46 No.01By Paul Goldberg
Drugs & Targets FDA approves Tecentriq + chemo as initial treatment metastatic non-squamous NSCLC indication December 06, 2019Vol.45 No.45
